Market Overview:
The global argininemia treatment market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of argininemia, rising awareness about the disease, and technological advancements in the field of argininemia treatment. The global argininemia treatment market can be segmented on the basis of type into oral and injection. The oral segment is expected to dominate the global argininemia treatment market during the forecast period owing to its ease of use and lower cost as compared to other treatments available for argininemia.
Product Definition:
Argininemia Treatment is the process of treating patients who have been diagnosed with argininemia. Argininemia is a rare genetic disorder that affects the body's ability to break down protein. This can lead to a build-up of ammonia in the blood, which can be toxic. Symptoms of argininemia include vomiting, confusion, and seizures. Treatment for argininemia usually involves managing symptoms and preventing complications.
Oral:
Oral is a term used for drugs that are administered by mouth. Oral drug products can be divided into two broad categories, licensed and unauthorized oral pharmaceuticals. Unlicensed or street drugs are the ones that people make up themselves and they are usually made from basic chemicals found in the home or garden.
Injection:
Injection is a medication used to treat argininemia. It works by increasing the amount of arginine in the body which is a type of amino acid that helps build urea cycle and help remove harmful ammonia from the body. In some cases, it may also be used to treat gout, an autoimmune disease where there is too much uric acid in blood causing pain and redness of skin.
Application Insights:
Drug stores and other application segments led the global argininemia treatment market in 2017. The growth can be attributed to increasing awareness about availability of a wide range of nutraceuticals for nutritional management, which is expected to drive demand over the forecast period.
The hospital segment is anticipated to witness significant growth over the forecast period owing to rising prevalence of diseases such as cystic fibrosis, wherearginine deficiency has been reported. In addition, growing R&D initiatives by major players for development of cost-effective drugs with fewer side effects will boost industry growth during future years.
Source: IMS Health; Analysis performed by GlobalData ¢â‚¬â€œ based on data published in NCBI (2016)Arginine plays an important role in maintaining cardiovascular system health.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of patients suffering fromargininemia and increased adoption of innovative therapies. The U.S., which accounted for the largest revenue share, is expected to maintain its dominance over the forecast period due to high healthcare expenditure and awareness about available treatment options among patients.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing patient pool with respect rising disposable income levels in emerging economies such as India & China, growing medical tourism industry,and government initiatives for improving healthcare infrastructure & facilities coupled with low cost treatment options are some factors that can be attributed towards this growth rate. Moreover, increasing R&D activities by various pharmaceutical companies will also boost regional market growth over next eight years (2018-2030).
Growth Factors:
- Increasing prevalence of argininemia
- Growing awareness about the disease and its treatment options
- Rising demand for novel therapeutics for argininemia
- Availability of government funding for research on argininemia treatment
- Technological advancements in the field of argininemia treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Argininemia Treatment Market Research Report
By Type
Oral, Injection
By Application
Hospital, Drugs Stores, Other
By Companies
Helsinn Healthcare, Novartis Pharmaceuticals, Horizon Pharma, Medicis Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Argininemia Treatment Market Report Segments:
The global Argininemia Treatment market is segmented on the basis of:
Types
Oral, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Stores, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Helsinn Healthcare
- Novartis Pharmaceuticals
- Horizon Pharma
- Medicis Pharmaceutical
Highlights of The Argininemia Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injection
- By Application:
- Hospital
- Drugs Stores
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Argininemia Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Argininemia is a rare disorder that results in low levels of arginine. Arginine is an amino acid that helps to form the proteins that make up the body's tissues and organs. People with argininemia may experience problems with their muscles, bones, and nerves. Treatment typically involves increasing the amount of arginine in a person's diet or using medications to increase production of arginine by the body.
Some of the major players in the argininemia treatment market are Helsinn Healthcare, Novartis Pharmaceuticals, Horizo​​n Pharma, Medicis Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Argininemia Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Argininemia Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Argininemia Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Argininemia Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Argininemia Treatment Market Size & Forecast, 2018-2028
4.5.1 Argininemia Treatment Market Size and Y-o-Y Growth
4.5.2 Argininemia Treatment Market Absolute $ Opportunity
Chapter 5 Global Argininemia Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Argininemia Treatment Market Size Forecast by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Argininemia Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Argininemia Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Stores
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Argininemia Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Argininemia Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Argininemia Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Argininemia Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Argininemia Treatment Market Size Forecast by Type
9.6.1 Oral
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Argininemia Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Stores
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Argininemia Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Argininemia Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Argininemia Treatment Market Size Forecast by Type
10.6.1 Oral
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Argininemia Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Stores
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Argininemia Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Argininemia Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Argininemia Treatment Market Size Forecast by Type
11.6.1 Oral
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Argininemia Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Stores
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Argininemia Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Argininemia Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Argininemia Treatment Market Size Forecast by Type
12.6.1 Oral
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Argininemia Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Stores
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Argininemia Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Argininemia Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Argininemia Treatment Market Size Forecast by Type
13.6.1 Oral
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Argininemia Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Stores
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Argininemia Treatment Market: Competitive Dashboard
14.2 Global Argininemia Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Helsinn Healthcare
14.3.2 Novartis Pharmaceuticals
14.3.3 Horizon Pharma
14.3.4 Medicis Pharmaceutical
